YIELD10 BIOSCI Revenue, Profits - YTEN Annual Income Statement

Add to My Stocks
$1.47 $0.02 (1.38%) YTEN stock closing price Jul 20, 2018 (Closing)

YTEN stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the YIELD10 BIOSCI stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2017 impacts the YTEN stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the YIELD10 BIOSCI profit and loss statement for 2017 total to $10.22M. This line item shows that the operating expenses has decreased compared with last year. Also check: YIELD10 BIOSCI assets and YIELD10 BIOSCI free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
YIELD10 BIOSCI Revenues or Net Sales
-1.15M2.59M2.8M5.39M42.31M1.42M-1.42M1.55M
Cost Of Goods Sold (COGS)---1.48M3.02M1.42M----
YIELD10 BIOSCI Gross Profit
-1.15M1.93M1.31M2.36M40.89M1.42M-1.42M1.55M
Research & Development Expense4.59M5.67M16.57M17.34M19.12M23.17M24.44M23.67M24.47M24.66M
Selling General & Admin Expense5.63M5.73M9.1M10.8M13.74M14.11M15.84M15.71M15.68M15.78M
Income Before Depreciation Depletion Amortization-9.28M-10.24M-23.74M-26.82M-30.5M3.6M-38.86M-38.93M-38.72M-38.89M
Depreciation Depletion Amortization----------
Non Operating Income-0.11M-0.03M-------2.88M
Interest Expense----------
YIELD10 BIOSCI Pretax Income
-9.39M-10.28M-23.68M-26.76M-30.5M3.63M-38.78M-38.8M-37.95M-36M
Provision for Income Taxes--1.09M--------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-9.39M-9.18M-23.68M-26.76M-30.5M3.63M-38.78M-38.8M-37.95M-36M
Extraordinary Items & Discontinued Operations-1.58M--2.76M------
YIELD10 BIOSCI Profit/ Loss (Net Income)
-9.39M-7.6M-23.68M-29.53M-30.5M3.63M-38.78M-38.8M-37.95M-36M
Average Shares used to compute Diluted EPS3.29M2.78M2.5M1.02M------
Average Shares used to compute Basic EPS3.29M2.78M2.5M1.02M------
Income Before Nonrecurring Items-9.4M-9.19M-23.68M-26.77M-30.51M3.63M-38.79M-38.8M-37.96M-36.01M
Income from Nonrecurring Items----------
YIELD10 BIOSCI Earnings Per Share Basic Net
-3.29-2.70-9.50-28.79-52.796.60-74.39-86.98-97.18-94.78
YIELD10 BIOSCI Earnings Per Share Diluted Net
-3.29-2.70-9.50-28.79-52.796.60-74.39-86.98-97.18-94.78
EPS Diluted Before Nonrecurring Items-3.29-3.30-9.50-26.40-52.796.60-74.39-86.98-97.18-94.78
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Honeywell financial analysis

It is very helpful to read a report on YIELD10 BIOSCI stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our YIELD10 BIOSCI revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like YIELD10 BIOSCI try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the YTEN income statement, one can check the YIELD10 BIOSCI historical stock prices to check how the price has moved with time.

YIELD10 BIOSCI Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
21.28
Dividend Yield
0%